The combination of both Aβ and tau-dependent transgenic mouse models of AD with validation in human donor brain tissue led us to identify the loss of distinct interneuronal sub-populations likely contributing to neuronal network failure in AD pathogenesis. Here, MAPT is linked to Alzheimer disease.